Barretos Cancer Hospital
hospitaldeamor.com.brLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
48
Active
4
Phase 3
5
Total enrollment
17,312
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Imiquimod | — | — | — | — | 2 |
Next readouts
- 2026-12-31
Top conditions
- Cervical Intraepithelial Neoplasia4
- Cancer3
- Breast Cancer3
- Colorectal Cancer2
- Cervical Cancer2
- Neoplasms2
- Anxiety Disorders2
- Biomarkers2
Frequently asked questions about Barretos Cancer Hospital
- How many clinical trials does Barretos Cancer Hospital have on ClinicalTrials.gov?
- Barretos Cancer Hospital is listed as the lead sponsor on 48 clinical trials in ClinicalTrials.gov, 4 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Barretos Cancer Hospital's trials are in Phase 3?
- 5 of Barretos Cancer Hospital's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Barretos Cancer Hospital focus on?
- Barretos Cancer Hospital's most-studied conditions on ClinicalTrials.gov are Cervical Intraepithelial Neoplasia, Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer.
- When are Barretos Cancer Hospital's next clinical trial readouts?
- Barretos Cancer Hospital has 1 upcoming primary-completion readout tracked here; the soonest is “Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod”, expected around 2026-12-31.